Stocktoria

Nexalin Technology, Inc. NXL

Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2022-09-16

Nexalin Technology, Inc. statistics & valuation

Market cap$7.3M
P / S24.2×
P / B1.9×
Net margin-2725.8%
Return on capital-223.9%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-4218.90% -128.50% -4197.60% -4508.70% -2725.80% 20212022202320242025
Gross margin (%)
85.10% 72.50% 76.80% 78.30% 79.70% 20212022202320242025
Operating margin (%)
-4177.70% -138.70% -5143.50% -4596.10% -2781.70% 20212022202320242025
Return on equity (%)
-31.00% -145.00% -206.90% -219.40% 20212022202320242025
Shares outstanding
4.9M 7.3M 7.4M 13.3M 19.2M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-806.40% -22.80% -128.00% -180.10% -177.40% 20212022202320242025
Free cash flow margin (%)
20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$0.30 -$0.63 -$0.83 -$0.50 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Gross margin79.7%78.3%76.8%72.5%85.1%
Operating margin-2781.7%-4596.1%-5143.5%-138.7%-4177.7%
Net margin-2725.8%-4508.7%-4197.6%-128.5%-4218.9%
Return on assets-177.4%-180.1%-128.0%-22.8%-806.4%
Return on equity-219.4%-206.9%-145.0%-31.0%361.4%
Current ratio4.857.258.073.810.32

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.